9 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Terminated 9 |
Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing a Risk Model for G6PD Deficiency primaquine, chloroquine + primaquine - Malaria, Vivax, G6PD Deficiency | Phase 4 | Terminated | PATH | 54 | 2018-05-07 | 2021-11-12 |
| Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy Artemether/Lumefantrine (AL) - HIV Infection, Malaria | Phase 4 | Terminated | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 19 | 2012-02-01 | 2014-05-19 |
| Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV) Mefloquine- Artesunate, Artemether-Lumefantrine, Chloroquine - Plasmodium Vivax Malaria | Phase 4 | Terminated | Centers for Disease Control and Prevention | 16 | 2011-02-01 | 2012-04-13 |
| Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in Brazil Artemether-Lumefantrine, Mefloquine- Artesunate - Malaria | Phase 4 | Terminated | Centers for Disease Control and Prevention | 6 | 2010-11-01 | 2012-04-13 |
| A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islands Sulphadoxine-pyrimethamine, Chloroquine prophylaxis - Malaria, Malaria in Pregnancy | Phase 4 | Terminated | Ministry of Health and Medical Services, Solomon Islands | 2504 | 2009-08-01 | 2010-07-07 |
| Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children Sulfadoxine Pyrimethamine - Malaria | Phase 4 | Terminated | Albert Schweitzer Hospital, Netherlands | 139 | 2007-03-01 | 2007-08-10 |
| Randomized Trial on Effectiveness of ACTs in Ghana Artesunate plus Amodiaquine, Artemether-Lumefantrine - Malaria, Falciparum | Phase 4 | Terminated | Bernhard Nocht Institute for Tropical Medicine | 245 | 2006-09-01 | 2007-11-27 |
| Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function Artemether-lumefantrine - Malaria, Falciparum | Phase 4 | Terminated | Novartis Pharmaceuticals | 265 | 2005-06-01 | 2012-04-27 |
| Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine Bacille Calmette Guerin (BCG) - Malaria | Phase 4 | Terminated | Bandim Health Project | 2871 | 2002-07-01 | 2008-10-21 |
Malaria, Falciparum (3) · Malaria, Vivax (2) · Anemia (1) · Glucosephosphate Dehydrogenase Deficiency (1) · HIV Infections (1) · Infant Death (1)
Infections (9) · Mosquito-Borne Diseases (9) · Parasitic Diseases (9) · Protozoan Infections (9) · Vector Borne Diseases (9) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Blood-Borne Infections (1) · Carbohydrate Metabolism, Inborn Errors (1) · Communicable Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Artemether, Lumefantrine Drug Combination (5) · Chloroquine (2) · fanasil, pyrimethamine drug combination (2) · Amodiaquine (1) · Artesunate (1) · Primaquine (1) · lactitol (1)
Centers for Disease Control and Prevention (2) · Albert Schweitzer Hospital, Netherlands (1) · Bandim Health Project (1) · Bernhard Nocht Institute for Tropical Medicine (1) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1) · Ministry of Health and Medical Services, Solomon Islands (1) · Novartis Pharmaceuticals (1) · PATH (1)
Brazil (2) · Gabon (1) · Ghana (1) · Guinea-Bissau (1) · Malawi (1) · Solomon Islands (1) · Thailand (1) · Uganda (1)
Anna Maria van Eijk, MD PhD (1) · Daniel Ansong, MD (1) · Francesca Aweeka, Pharm.D. (1) · Martin P Grobusch, MD (1) · Meghna Desai, MPH PhD (1) · Meghna Desai, PhD MPH (1) · Peter Aaby (1) · Saadou Issifou, MD MSc (1)
U01AI068632 (1)